Simile Raises $200 Million Series B at $2 Billion Valuation
Simile raised a $200 million Series B at a $2 billion valuation. The round was led by Greenoaks Capital, with participation from Index Ventures, Hanabi Capital, Bain Capital Ventures, A*, Factory, CVS Health Ventures, and new investor Definition.
The company said the funding will support development of its foundation model for human behavior and help scale its simulation platform. The round follows a $100 million Series A led by Index Ventures five months ago, when Simile emerged from stealth.
Organizations including CVS Health and Wealthfront are using Simile to simulate human behavior and test decisions before using them in live settings. CVS Health has used the platform for customer research validation, patient satisfaction analysis, medication adherence planning, competitive benchmarking, and modeling patient groups that are hard to reach.
Simile is also working with Gallup on AI powered simulations for policy research, trend analysis, workplace studies, and social research. The company was founded by CEO Joon Sung Park.
We hope you enjoyed this article
Consider subscribing to one of our newsletters like Enterprise AI Brief, AI Funding Brief or Daily AI Brief.
Also, consider following us on social media:
More from Enterprise
Nov 12 Adobe Express AI Editing Is Coming to Microsoft Photos Nov 12 Lloyd's Register Expands Maritime AI Readiness Index Nov 11 Databricks Updates Genie for Multistep Business Tasks Nov 11 Optum and Alameda Alliance Partner on AI Claims Automation Nov 11 INVE Technologies Partners With Trackonomy on Physical AI SoftwareMore from Funding
Nov 12 Octave Acquires Cerebre for Industrial AI Plant Models Nov 11 StitchStudio raises $8M for insurance AI products Nov 11 Stage 2 Capital Closes $100 Million for B2B AI Investments Nov 11 Enza Capital secures $21 million for African AI fund Nov 11 Goldman Sachs Forecasts Anthropic Revenue of $685 Billion by 2030Enterprise AI Brief
Weekly report on AI business applications, enterprise software releases, automation tools, and industry implementations.
Industry analysis
2025 Global Business Services Agenda: Gen AI Takes Center Stage
This industry analysis by The Hackett Group explores the transformative impact of generative artificial intelligence (Gen AI) on global business services (GBS) in 2025. The study highlights the shift from exploration to acceleration of Gen AI initiatives, with 89% of executives advancing these projects to improve customer satisfaction, innovate products, and reduce costs. The report also discusses the challenges and strategies for successful Gen AI adoption, emphasizing the need for a technology-enabled operating model and the importance of reskilling the workforce.
Read moreYou may also like
Symbe Raises $5.7 Million for AI Sales Platform
Isomorphic Labs Seeks $5 Billion at $50 Billion Valuation
42AI exits stealth with $62.5 million in seed funding
Atlas Bio raises $12.5 million for virtual drug trials
Adsilico Raises £10 Million for Virtual Medical Device Testing
Daily AI Brief: the AI news that matters, in your inbox.